Offer - Urjas Oil for just ₹ 1
Colette 0.25 Mg Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Acromegaly, Prolactinoma.
The correct dosage of Colette 0.25 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Colette 0.25 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Colette 0.25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Colette 0.25 Mg Tablet's effect during pregnancy is Mild and Severe while nursing. In addition, Colette 0.25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Colette 0.25 Mg Tablet related warnings section.
Colette 0.25 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Colette 0.25 Mg Tablet in conditions like High Blood Pressure, Heart Disease, Depression. Some other conditions that can be affected by Colette 0.25 Mg Tablet are listed in the contraindications section below.
Besides this, Colette 0.25 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Colette 0.25 Mg Tablet is considered not safe while driving, and is not addictive.
Colette 0.25 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Colette 0.25 Mg Tablet safe for pregnant women?
Pregnant women may get mild side effects from Colette.
Is the use of Colette 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Colette. So it is adviced to consult the doctor before using it.
What is the effect of Colette 0.25 Mg Tablet on the Kidneys?
Kidney can be affected by Colette. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Colette 0.25 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Colette. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Colette 0.25 Mg Tablet on the Heart?
The heart can be affected by Colette. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Colette 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Colette 0.25 Mg Tablet habit forming or addictive?
No, you will not get addicted to Colette 0.25 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Colette 0.25 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Colette 0.25 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Colette 0.25 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Colette 0.25 Mg Tablet
Due to a lack of research, nothing can be said about the consequences of taking Colette 0.25 Mg Tablet together with food.
Interaction between Alcohol and Colette 0.25 Mg Tablet
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)
